logo AIRI

Publications archive

The Innovations of the Near Future - Pharmaceuticals

The Innovations of the Near Future - Pharmaceuticals Priority Technologies
Download

Airi, Farmindustria, Bracco Imaging, Dompé Farmaceutici, Fondazione Don Gnocchi, GSK, Menarini, Pfizer, Università di Modena e Reggio Emilia, Università di Napoli Federico II e Vertex Pharmaceuticals.

Publication date:
Health Pharmaceutical

The Airi study identifies 9 technological scenarios that, along with others, will enhance the competitiveness, productivity, and sustainability of both the public and private sectors, improving people's health but that, starting today, require investments in technology, processes, and skills.

For each technological scenario, the study provides an analysis of the reference context and the expected socioeconomic and health impacts, then illustrates the motivations for development, the state of the art of the technology, and an estimate of the necessary investments in the short to medium term, where available.


The challenges for the pharmaceutical industry in Italy are numerous: some are global in nature, such as Europe's loss of ground in terms of investments compared to the USA and China; others are transversal to other sectors: the use of Artificial Intelligence and other emerging technologies increasingly determining for competitiveness; still others are more closely related to the Italian context, such as the need to rethink public care and assistance modalities.

Read the press release

Sector profiles:

  • The pharmaceutical industry in Italy
  • Characteristics of pharmaceutical companies
  • Production and export
  • Employment
  • Research and development
  • Clinical trials
  • Investments in R&D and characteristics of the pipeline at the global level


Technological scenarios:

  • 1 - Technological platforms for the development of biopharmaceuticals
  • 2 - New technological platforms for the development of bacterial vaccines relevant in the fight against antimicrobial resistance
  • 3 - Drugs for advanced therapies
  • 4 - Innovative artificial intelligence technologies for drug discovery
  • 5 - Digital & connected care: from health technologies to digital therapeutics
  • 6 - New developments in diagnostic imaging: molecular imaging and theranostics
  • 7 - New developments in diagnostic imaging: artificial intelligence in radiology
  • 8 - Technologies for precision diagnostics through liquid biopsy
  • 9 - Nanomedicine